From RCTs to Real-World: Supraflex Cruz Clinical Outcomes in 2025

 

 

Agenda:

  • Discussion on the design and outcomes of three clinical trials involving Supraflex Cruz DES : RCTs – Tuxedo-II, Multivessel Talent, and Registry – Cruz Senior.

 

FACULTY

Patrick W Serruys, MD, PhD  

Patrick W Serruys, MD, PhD
National University of Ireland
Galway, Ireland

Sripal Bangalore, MD, MHA  

Sripal Bangalore, MD, MHA
NYU Grossman School of Medicine
New York, NY

David M. Leistner, MD  

David M. Leistner, MD
University Heart Center Frankfurt
Frankfurt, Germany

     

 

This program was supported by:

 

 

SMT